Bioelectric medications are a great alternative to pharmaceutical therapies which require continuous infusion of chemicals into the body and reduce the number of undesirable effects that patients may encounter.
This report for Global Bioelectric Medicine Market segmented is segmented by product type, surgical requirement, application, end-users and geography.
Bioelectric medicine Market anticipated to expand at CAGR of 6% from 2023 to 2032.
The bioelectric medicine market size was estimated to be US$ 20.3 billion in 2021.
The market category for implantable cardioverter defibrillators held the biggest share due to the product's widespread use in arrhythmia.
Second Sight Medical Products, Inc., SetPoint Medical, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Cochlear Limited, electroCore, Inc., Inspire Medical Systems, Inc., Nuvectra Corporation, NeuroMetrix, Inc, LivaNova Plc, Medtronic Plc, MED-EL, Nevro Corp., Omron Corporation, Pixium Vision, and Stimwave LLC are some of the major key players.
The growing aging population in developed and developing countries, as well as the rising prevalence of disorders in the senior population, is driving bioelectric medicine market expansion.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved